Location: Home
  • search
  • go
  • Relate News
  • 1/30/2023CDE Solicits Comments on eCTD Implementation Guide V1.1 and eCTD Valid...
  • 1/30/2023NHSA Initiates 8th National Level Centralized Drug Purchase Tender
  • 1/30/2023Chongqing Zhifei Renews Supply, Distribution And Co-Promotion Agreemen...
  • 1/30/2023Zennova Opens Manufacturing and R&D Center in China
  • 1/29/2023Recent Executive Moves
  • 1/29/2023NMPA Adopts ICH Guidelines Q3D(R2) and M10 in China
  • 1/28/2023SinoBiopharma's invoX and F-star Thera in Active Discussion with CFIUS...
  • 1/28/2023J&J, Legend's Carvykti Beat Standard Therapy in Earlier Myeloma, Thre...
  • 1/26/2023Prospects for European Companies in China in 2023
  • 1/25/2023Newly Approved Cancer Drugs in China — Innovation and Clinical Benefi...
  • 1/25/2023Pharma Cos That Develop Vaccines With Efficacy Against Omicron Variant...
  • 1/25/2023GMB and MeNow Announce Collaboration for AI Development of TCM-Based S...
  • 1/24/2023Takeda to Acquire Ex-China License of HUTCHMED's Fruquintinib
  • 1/24/2023China's Drug-Pricing Policy Impedes Biotech Profits (Financial Times)
  • 1/20/2023Funding for Biopharmaceuticals Plummeted in 2022 with Investments Flow...
  • 1/20/2023Look out, AbbVie and J&J. BeiGene's Brukinsa Just Scored A Key Leukemi...
  • 1/20/2023China Anti-Rheumatic Drug Market - Growing Prevalence of Rheumatic Pat...
  • 1/20/2023Drug R&D and Product Registration News Digest January 2023 (3)
  • 1/19/2023CDE Issues the Provisions for GLP Certification of Drug Non-Clinical R...
  • 1/19/2023CDE Issues the Guidelines for Clinical R&D of New Drugs for Chronic Ly...
  • 1/19/2023China Issues the Measures for Linking the Drug Administrative Law Enfo...
  • 1/19/2023NHC Issues Notice to Step Up Clinical Use Regulation of Pediatric Drug...
  • 1/19/2023After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
  • 1/19/2023AbbVie, Novartis and More Win National Coverage in China Even as Pfize...
  • 1/19/2023Chinese Market Biosimilar Update (JDSupra)
  • 1/18/2023Lilly and AffaMed Enter Pact for Commercialization of Migraine Drug Ga...
  • 1/18/2023China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...
  • 1/18/2023NHSA and MOHRSS Jointly Issues the 2022 National Drug Reimbursement Li...
  • 1/18/2023Moderna in Active Discussions with China to Supply COVID Vaccines
  • 1/17/2023Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio
  • Page:129/790 Total number of articles:23683: [First][<<] [127] [128] [129] [130] [131] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group